Feasibility study of Docetaxel plus Bevacizumab in selected patient with previously treated advanced NSCLS(non-squamous).
Phase of Trial: Phase II
Latest Information Update: 30 Sep 2013
At a glance
- Drugs Bevacizumab (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 30 Sep 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 27 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 09 Nov 2011 New trial record